Waters resumed with an In Line at Evercore ISI

Core Viewpoint - Evercore ISI has resumed coverage of Waters (WAT) with an In Line rating and a price target of $360, following a 13% decline in shares after the Becton Dickinson (BDX) Life Sciences transaction due to mixed results and cautious guidance [1] Group 1 - The analyst highlights that the current debate revolves around management's confidence in the merits of the deal versus short-term concerns [1]